La Jolla, CA, United States of America

Zoya Kai

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zoya Kai: Innovator in Cognitive Health

Introduction

Zoya Kai is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of cognitive health, particularly in the treatment of cognitive decline and Alzheimer's disease. Her innovative work focuses on developing compounds that can potentially improve the quality of life for individuals affected by these conditions.

Latest Patents

Zoya Kai holds a patent for "Inhibitors of cognitive decline." This patent includes compounds that are central nervous system drug candidates aimed at treating cognitive decline, specifically Alzheimer's disease. The patent also outlines methods for treating, inhibiting, and abating cognitive decline using a derivative of ginger oil. Additionally, it provides a method for conditioning biological extracts, such as medicinal plant extracts, through a reductive amination process to create nitrogen-containing derivatives. She has 1 patent to her name.

Career Highlights

Zoya Kai is currently associated with Cognition Therapeutics, Inc., where she continues her research and development efforts. Her work is pivotal in advancing therapeutic options for cognitive health, and she is recognized for her innovative approach to drug development.

Collaborations

Zoya collaborates with esteemed colleagues, including Gilbert M. Rishton and Hiromi Arai. Their combined expertise enhances the research and development efforts at Cognition Therapeutics, Inc.

Conclusion

Zoya Kai is a trailblazer in the field of cognitive health, with her innovative patents and collaborative efforts contributing to the fight against cognitive decline and Alzheimer's disease. Her work exemplifies the impact of innovation in improving health outcomes for individuals facing these challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…